Olivier Bouché

Centre Hospitalier Universitaire de Reims

Also affiliated with Université de Reims Champagne-Ardenne

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: “FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer”.

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

New England Journal of Medicine(2011)10.1056/nejmoa1011923

N/A

1.3DataRank · unranked

6381 citations

Françoise Desseigne, Marc Ychou, Olivier Bouché, Rosine Guimbaud, Yves Bécouarn +21 more

Feasibility and Impact of Adapted Physical Activity (APA) in Cancer Outpatients Beginning Medical Anti-Tumoral Treatment: The UMA-CHAPA Study

Cancers(2022)10.3390/cancers14081993

N/A

0.208DataRank · unranked

3 citations

Marine Perrier, Camille Mazza, Anne Quinquenel, Mathilde Brasseur, Alain Delmer +7 more

PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon

Cancer Discovery(2022)10.1158/2159-8290.cd-21-0521

N/A

0DataRank · unranked

79 citations

Ivan Bièche, Éric Pasmant, Nadim Hamzaoui, Nicolas Leulliot, Lucas Michon +51 more